Viridian Therapeutics Eulerpool naujienos

Viridian Therapeutics Eulerpool News

Viridian Therapeutics akcijų naujienos

Viridian Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Viridian Therapeutics naujienas mes pateikiame čia.

• liepos 25 d. ·

  Yahoo
  Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
• liepos 25 d. ·

  Thefly.com
  Viridian Therapeutics completes enrollment in THRIVE-2 trial
• liepos 18 d. ·

  TipRanks
  Buy Rating for Viridian Therapeutics on VRDN-001 Clinical Advancements and Market Potential
• liepos 16 d. ·

  Thefly.com
  Wedbush reveals three potential buyout targets for Biogen
• liepos 3 d. ·

  Yahoo
  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• birželio 20 d. ·

  TipRanks
  Viridian Therapeutics’ Shareholders Approve Equity Plan Expansion
• birželio 12 d. ·

  SeekingAlpha
  Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
• birželio 12 d. ·

  TipRanks
  Ladenburg Thalmann & Co. Remains a Hold on Viridian Therapeutics (VRDN)
• birželio 11 d. ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Longboard Pharmaceuticals (LBPH) and Viridian Therapeutics (VRDN)
• birželio 11 d. ·

  Yahoo
  Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease